http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SV-2017005417-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd45cc9c0c2281fde5065524e8d6090
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98990e4a5c86f0d516d1ee963b318a10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49359d5758e4125e46dd1d4a113d74e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_102f323829ea35e610998ca58d10f686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7997126de7f7e531e4bb5a8f94f1d3a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58ef1669808b2f6e36fef294fb6b5c17
publicationDate 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SV-2017005417-A
titleOfInvention SOLID PHARMACEUTICAL COMPOSITION INCLUDING AMLODIPINO AND LOSARTÁN
abstract THIS INVENTION PROVIDES A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CARDIOVASCULAR DISORDERS CONTAINING LOSARTAN OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME; AMLODIPINO OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME; A DISINTEGRANT; AND A COATING AGENT. THE COMPOSITION OF THE PRESENT INVENTION, WHICH HAS THE BEST COMBINATION AND OPTIMAL RELATIONSHIP OF A DISINTEGRANT TO A COATING AGENT, SHOWS SUFFICIENT RESISTANCE AND HIGH DISSOLUTION RATES UNDER VARIOUS ENVIRONMENTS OF PH, AND THIS WAY, IS USEFUL AN EXCELLENT SOLID FORMULATION THAT SHOWS DRUG SUPPLY EFFICIENCY. AND IMPROVED STORAGE STABILITY
priorityDate 2014-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378

Total number of triples: 37.